Siemens, Jefferies recommended a buy on IIFL Finance, JPMorgan has an overweight rating on Max Healthcare, and Macquarie maintained an outperform rating on Tata Motors.
Macquarie maintained an outperform rating on Tata Motors with a target price of Rs 1,028. Pure play structure is likely to drive better value discovery.
The conglomerate structure was constraining valuation upside. The Pure-play structure lends investment flexibility to investors.
PV segment valuation discount to Maruti could narrow if Tata delivers on market-share gains/better margins.
JPMorgan maintained an overweight rating on Max Healthcare with a target price of Rs 888. Max Healthcare is a high-conviction idea. The stock is available at an attractive entry level and the growth prospects remain intact.
The global investment bank believes that the SC directive will be difficult to implement and hence recommends investors use this weakness as a buying opportunity.
The stock trades at an attractive valuation of 24x FY26E EBITDA, a ~20% premium to the sector average, and a ~10% discount to Medanta.
Jefferies maintained a buy rating on IIFL Finance with a target price of Rs 765. The Reserve Bank of India (RBI) restricts disbursing Gold Loans.
There is a potential risk to earnings if